Key facts
- Status: Out of Business.
- ·Watchlist + deal alerts for Kepler AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Kepler AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kepler AI
Developer of enterprise-grade bioinformatics automation software designed to accelerate research workflows in life sciences and pharmaceutical domains. The company's platform integrates AI agents for data analysis, experiment planning, literature review, and workflow orchestration, enabling research teams, biotech firms, and pharmaceutical companies to enhance scientific productivity, reduce manual effort, and improve the accuracy and reproducibility of complex biological research processes.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 5
- Website
- getkepler.ai/
- Ownership
- Out of Business
Kepler AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kepler AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kepler AI in its N-PORT filings yet. We sweep new filings monthly.